Adjuvants to L-Dopa for Parkinsonism.

BMJ
doi 10.1136/bmj.2.5708.540
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Stereotactic Thalamotomy and L-Dopa Induced Involuntary Movement in Parkinsonism

Neurologia Medico-Chirurgica
SurgeryNeurology
1973English

L-Dopa and Carbidopa (Sinemet) in the Management of Parkinsonism

Postgraduate Medical Journal
Medicine
1975English

Subcortical Vascular Lesions Predict Functional Recovery After Rehabilitation in Patients With L-Dopa Refractory Parkinsonism

Journal of the American Geriatrics Society
GerontologyGeriatrics
2004English

L-Dopa for Parkinson's Disease - A Bittersweet Pill

European Journal of Neuroscience
Neuroscience
2018English

Hypotension Caused by L-Dopa.

BMJ
1970English

L-Dopa Methyl Ester Antagonizes Competitively L-Dopa-Induced Facilitation of Noradrenaline Release From Rat Hypothalamic Slices.

The Japanese Journal of Pharmacology
1990English

Failure of Vitamin B6 to Reverse the L-Dopa Effect in Patients on a Dopa Decarboxylase Inhibitor

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1971English

The Structure of L-Mimosine, an L-Dopa Analogue.

Acta Chemica Scandinavica
1973English

Opioid System in L-Dopa-Induced Dyskinesia

Translational Neurodegeneration
Molecular NeuroscienceNeurologyCellularCognitive Neuroscience
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy